Introduction: Tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like polypeptide-1 receptor agonist, has significantly increased in use in overweight (OW)/obese people with type 1 diabetes (T1D). It is... ...

请注册登录后继续浏览